PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
Discussing Rheumatology: November 2023
Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
AxSpA Podcast: Safety and Efficacy of Upadacitinib
CSF Author Interview: Dr. David Martin, 2023
Discussing Rheumatology: October 2023
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer
Author Interview: Professor Martin Bergman, 2023
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
Discussing Rheumatology: September 2023
Author Interview: Sofia Ramiro
Discussing Rheumatology: August 2023
AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue
Discussing Rheumatology: July 2023
PsA Podcast: Secukinumab in Oligoarticular PsA & JAK Inhibition-related Malignancies
Author Interview: Laura Coates
Author Interview: Mark Russell
Discussing Rheumatology: June 2023
AxSpA Podcast: Secukinumab Optimisation & Ixekizumab Treatment for PAEs
Discussing Rheumatology: May 2023
Author Interview: Shikha Singla
AxSpA Podcast: AS Associated MACE & Upadacitinib's Long Term Safety
Discussing Rheumatology: April 2023
PsA Podcast: Herpes Zoster in JAK Inhibitor Therapies & The APEX Protocol
Discussing Rheumatology: March 2023
Discussing Rheumatology: February 2023
Discussing AxSpA: Episode 5
Discussing Rheumatology: January 2023
Author Interview: Kevin Winthrop
Discussing PsA: Episode 5
Author Interview: Rebecca Haberman
